MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
CELLECTIS - ADR

Cellectis - ADR

XNAS: CLLS

Momentum Trap

Download real time

3.42 0.09 (2.70%)

37.59% Fall from 52W High

33,719

XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Board Meeting

The latest board meeting for Cellectis (ADR) took place on 13 Mar 2026, for the purpose of Cellectis SA Fourth Quarter Earnings Result for 2025 See details

Cellectis (ADR) - CLLS - stock price prediction, stock price target, analyst ratings from 5 analysts

Cellectis (ADR) has a share price target of US$ 7, revenue growth forecast of 59.5%, and profit growth estimate of -63.1% for FY25, based on top 5 analyst calls.

37.59% Fall from 52W High

Cellectis (ADR) - CLLS - stock price prediction, stock price target, analyst ratings from 5 analysts

Cellectis (ADR) has a share price target of US$ 7, revenue growth forecast of 59.5%, and profit growth estimate of -63.1% for FY25, based on top 5 analyst calls.

Forecaster Screeners